JCI Editorial Board
potential first-tier conflicts of interest

Updated March 1, 2024

Go to the JCI's conflict-of-interest policy

 

AbbVie (S.E. Quaggin)

AccureX (D. Krainc)

Alnylam (A.B. Heimberger)

Aplexis Inc. (P. Ji)

Arvinas (M. Hussain)

AstraZeneca (M. Hussain)

Bayer (M. Hussain)

Biofluid Technology (E.M. McNally)

Biohaven (A.L. George Jr.)

BioMed Central (H. Perlman)

Boehringer Ingelheim (G.D. Barish)

Calidi Biotherapeutics (M.S. Lesniak)

Caris Life Sciences (A.B. Heimberger)

Cell IDx (E.M. McNally)

Cytokinetics (E.M. McNally)

Gateway Biome (E.B. Chang)

Genentech (M. Hussain)

Ikaika Therapeutics (E.M. McNally)

Inomagen Therapeutics (R.K. Arora)

Intellia Therapeutics (D. Krainc)

Ionis (J. Bass)

Lakeside Discovery (E.M. McNally, A. Shilatifard)

Leal Therapeutics (D. Krainc)

Leducq Foundation (H. Ardehali)

Lung Healing Technologies (A. Bharat)

Lung IQ LLC (A. Bharat)

Mannin Research Inc. (S.E. Quaggin)

Medtronic (J. Bass, J.E.)

Michael J. Fox Foundation (D. Krainc)

Moonlight Bio (J. Choi)

Nfold (S. Eisenbarth)

Novartis (E.M. McNally)

Oligo Foundry (E.M. McNally)

Omega Therapeutics (A. Shilatifard)

OrbiMed (D. Krainc)

PepGen (E.M. McNally)

Pfizer (N.S. Chandel, E.M. McNally)

Rafael Pharmaceuticals (N.S. Chandel)

Regeneron (J. Bass)

Riptide LLC (E.M. McNally)

Tenaya Therapeutics (E.M. McNally)

Thermo Fisher Scientific (J. Bass)

UptoDate Inc. (L.A. Godley)

Vanqua Bio (D. Krainc)

Vertex Pharmaceuticals (J. Bass)

Visiongate LLC (A. Bharat)

Vortex Therapeutics (S.A. Abdulkadir)

Zoe Biosciences (D.E. Vaughan)